trending Market Intelligence /marketintelligence/en/news-insights/trending/f13szcvvsqiqdmbaaz-xcw2 content esgSubNav
In This List

BioSig implementing 1-for-2.5 reverse stock split for Nasdaq uplisting

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


BioSig implementing 1-for-2.5 reverse stock split for Nasdaq uplisting

BioSig Technologies Inc. said it will implement a 1-for-2.5 reverse split of its common stock after the close of business Sept. 10 to meet requirements for its Nasdaq uplisting.

The Los Angeles-based development stage medical device company said its stock will begin trading on a split-adjusted basis from Sept. 11.

The reverse split was approved by BioSig's stockholders July 30.

BioSig's first product, the PURE EP System, which records and calculates electrocardiographic and intracardiac signals, among other things, for patients undergoing electrophysiology procedures in a laboratory, was approved by the U.S. Food and Drug Administration in August.